Federal contractor · GAITHERSBURG, MD
MEDIMMUNE LLC
No contract obligations recorded for MEDIMMUNE LLC in FY2026. Since FY2017: -$83.6M.
- Obligations · FY2026
- $0
- New awards
- 0
- Sole-source
- —
- Single offer
- —
- UEI
- PHXNKFPB76E7
- Parent company
- ASTRAZENECA UK LTD
Company family
Grouped from reported parent companies (UEI) and, where marked, AI judgments that two records name the same organization or group.
Part of the ASTRAZENECA PHARMACEUTICALS LP company family: 3 registered entities, $734.1K in FY2026 together. See the family
- ASTRAZENECA PHARMACEUTICALS LPWILMINGTON, DE · Family page$500
- ALEXION PHARMACEUTICALS INCNEW HAVEN, CT$733.6K
Spending by fiscal year
Obligations per federal fiscal year (October–September).
- 0FY2017
- -59.3MFY2018
- -2.4KFY2020
- 17.8KFY2022
- 18.4KFY2023
- 0FY2024
- -24.3MFY2025
Top buying agencies
Obligations in FY2026.
No contract obligations recorded for MEDIMMUNE LLC in FY2026.
What was bought · Where the work was performed
Obligations in FY2026.
What was bought
Where the work was performed
Integrity signals
Shares of the year's obligations, next to the country's.
Federal grants & assistance received
Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.
MEDIMMUNE LLC received $0 in federal assistance in FY2026, on 0 actions (0 new awards).
- Assistance · FY2026
- $0
- New awards
- 0
- Actions
- 0
- Since FY2021
- $4.4M
Assistance by fiscal year
- 4.4MFY2021
- 0FY2022
- 0FY2023
- 0FY2024
Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2024.
Teaming partners
Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.
Companies it pays
No subawards reported to other companies.
Primes that pay it
1 company · $112.2K reported
- BOSTON, MA · 1 subaward
Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.
Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 8, 2026, loaded Oct 8, 2026 · Subawards loaded from 2021.
Lobbying and PAC activity
Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.
Across the company family of ASTRAZENECA PHARMACEUTICALS LP (3 recipients).
Matched organizations
- AstraZeneca Pharmaceuticals LPAI match · 100%
- ALEXION PHARMACEUTICALS INC.AI match · 99%
- ALEXION PHARMACEUTICALS INC. PACAI match · 99%
- Lobbying · 2025
- $5.1M
- 29 reports
- Lobbying · 2023–2026
- $15.9M
- $15.9M in its own reports
- PAC giving · 2026
- $450.5K
- 2 PACs
Lobbying by year
- 2023$3.9M22 reports
- 2024$2.9M25 reports
- 2025$5.1M29 reports
- 2026$4M12 reports
Top issues
- Health issues74 reports
- Medicare and Medicaid61 reports
- Pharmacy15 reports
- Copyright, patent and trademark14 reports
- Taxation and the Internal Revenue Code14 reports
- Labor issues, antitrust and workplace6 reports
- Miscellaneous tariff bills5 reports
- Clean air and water4 reports
Who was contacted
- U.S. HOUSE OF REPRESENTATIVES75 reports
- U.S. SENATE69 reports
- White House Office30 reports
- Health & Human Services - Dept of (HHS)25 reports
- Food & Drug Administration (FDA)8 reports
- Labor - Dept of (DOL)6 reports
- U.S. Trade Representative (USTR)6 reports
- Commerce - Dept of (DOC)4 reports
Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).
Lobbying firms hired
- Todd Strategy Group$1.1M15 reports
- W Strategies, LLC$1.1M14 reports
- FEROX STRATEGIES$840K14 reports
- Forbes-Tate$700K14 reports
- PRIME POLICY GROUP$290K6 reports
- Manatt, Phelps, and Phillips$60K5 reports
- JEFFREY J. KIMBELL & ASSOCIATES, INC.$40K6 reports
Registrants who are individuals are counted, not named.
PAC giving to candidates by party, 2026 cycle
- Democratic$242K54%
- Republican$208.5K46%
PACs sponsored
- ZENECA INC. POLITICAL ACTION COMMITTEE (AZPAC)$901K raised this cycle
- ALEXION PHARMACEUTICALS INC. PAC$130K raised this cycle
PACs these organizations sponsor (connected organizations in FEC records). A PAC gives employees' and members' voluntary contributions, not the company's own money.
Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.
Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 7, 2026, loaded Oct 7, 2026 · 2023–2026.
Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 8, 2026, loaded Oct 8, 2026 · 2026, 2024, 2022.
Matches: Analisa AI name judgments (entity-match@1), updated Oct 5, 2026.
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026.